Joseph Patrick Martin, Jr

Title: Joseph Patrick Martin, Jr.: Pharmaceutical Inventor

Introduction

Joseph Patrick Martin, Jr. is an inventor associated with Richland, Michigan, United States, and Pharmacia & Upjohn Company. His patent work concerns oxazolidinone compounds and methods for assessing their potential antimicrobial properties.

Latest Patents

Martin is credited with 2 patents, including two inventions related to oxazolidinone antibiotics.

“Assay for Determining Oxazolidinone Antibiotics Having Minimum Monoamine Oxidase Inhibitory Activity” describes antimicrobial oxazolidinone compounds and an assay for evaluating their inhibitory activity against human monoamine oxidase. The disclosed compounds include variations in which specified substituents are methyl, ethyl, cyclopropyl, or dichloromethyl, while other positions may contain hydrogen or fluorine.

“S-Oxide and S,S-Dioxide Tetrahydrothiopyran Phenyloxazolidinones” presents compounds intended for use as antimicrobial agents. The patent describes oxazolidinone structures with tetrahydrothiopyran groups in S-oxide or S,S-dioxide forms and identifies variations in their chemical substituents.

Career Highlights

Martin’s listed patent contributions reflect research into antimicrobial drug candidates and the evaluation of their biological activity. His work connects compound design with testing for a specific potential safety concern: inhibition of human monoamine oxidase.

Collaborations

Martin’s listed coworkers include Toni-Jo Poel and Michael R. Barbachyn. His company affiliation is Pharmacia & Upjohn Company.

Conclusion

Joseph Patrick Martin, Jr.’s patent record highlights pharmaceutical research focused on oxazolidinone antimicrobial compounds and assays for evaluating their activity.